Pharmafile Logo
Pharmafocus logo
Advanced Search
rd_hands

Takeda secures $312 million zika vaccine development contract

September 5, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization

Takeda has announced that it has been granted a $312 million contract from the US government to develop an inactivated, …

News
hils

Clinton announces plan to tackle “unjustified price hikes”

September 5, 2016
Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes

US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …

News
gsk_boronia_australia

GSK announce positive results for chronic obstructive pulmonary disease treatment

September 5, 2016
Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease

GlaxoSmithKline and its partner Innoviva have announced that its Relvar Ellipta achieved positive results in its COPD Salford lung study …

News
merck_and_co

MSD drops osteoporosis trial drug due to stroke risk

September 5, 2016
Research and Development, Sales and Marketing MSD, Merck, Odanacatib, osteoporosis, stroke

MSD, known as Merck in the US and Canada, has announced that it has finally decided to discontinue the development …

News
astrazeneca_sign_sky

AZ’s first respiratory biologic meets primary endpoints in Phase III trials

September 5, 2016
Research and Development, Sales and Marketing AstraZeneca, asthma, benralizumab, biologic, respiratory, severe asthma

AstraZeneca has presented Phase III data at the European Respiratory Society (ERS) international congress which shows that trial biologic benralizumab …

News
top_ten

Top ten stories in the pharmaceutical industry this week

September 2, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile.com, top ten

As Mylan is left reeling from the backlash on its EpiPen price increase in the US, many lost their jobs …

News

FDA fast track designation for Biogen’s investigational Alzheimer’s treatment

September 2, 2016
Medical Communications, Research and Development Alzheimer's, Alzheimer’s, Biogen, FDA, aducanumab, fast track

Biogen has announced that its investigational Alzheimer’s disease treatment aducanumab has been granted fast track designation by the FDA. The …

News
amgen_flag

Amgen’s leukaemia treatment given FDA thumbs up for use in paediatric patients

September 2, 2016
Medical Communications, Sales and Marketing Amgen, FDA, blincyto, leukaemia

Amgen has announced that the FDA has approved the supplemental Biologics License Application for Blincyto (blinatumomab) in the treatment of …

News

NICE recommends Bayer’s Xofigo for prostate cancer treatment

September 2, 2016
Medical Communications, Sales and Marketing Bayer, NICE, approval, prostate cancer, recommendation, xofigo

NICE has issued final draft guidance recommending Bayer’s Xofigo (radium-223 dichloride) for the treatment of prostate cancer. Previously, the drug …

News
abpi_reception_right

ABPI welcomes Roche back into the fold eight years after suspension

September 1, 2016
Medical Communications, Research and Development ABPI, Roche, rejoin, suspension

Less than a decade after the company was suspended, Roche has now successfully re-joined the Association of the British Pharmaceutical …

News

Sepha is fast packing with a new EZ Blister upgrade.

September 1, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Packaging Equipment Specialist, Sepha, has released a functional upgrade for one of its original products, EZ Blister, the lab scale …

News
Press release
cloud

Cloud on the horizon: Cloud computing and the clinical trial

September 1, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, ICON, clinical trials, ibm

 Originally published in the September edition of Pharmafocus, Matt Fellows investigates how cloud computing may just be the answer the …

Feature

Eli Lilly elects Jamere Jackson to board of directors

September 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has elected Jamere Jackson to its board of directors, effective 1 October, where he will serve on the …

Appointment
novartis_iobmr

Up to 120 jobs set to go as Novartis closes down Cell and Gene Therapies unit

September 1, 2016
Manufacturing and Production, Research and Development CAR-T, Novartis, cart, cell and gene therapies

News has emerged that Novartis plans to close down its Cell and Gene Therapies unit, with up to 120 workers …

News

Lars Rebien Sørensen to retire as CEO of Novo Nordisk

September 1, 2016
Novo Nordisk, appointment

Novo Nordisk has announced that its president and CEO Lars Rebian Sørensen (pictured) is to retire at the end of …

News
roche_close

Roche’s Tecentriq meets primary endpoints in Phase III lung cancer trial

September 1, 2016
Research and Development PD-L1, Roche, keytruda, nivolumab, opdivo, phase III, tecentriq

Roche has presented new Phase III data for cancer immunotherapy Tecentriq (atezolizumab), which shows a clinically meaningful improvement in overall …

News
pfizer_chrome_plate

Pfizer nabs EU approval for Xalkori for certain lung cancers

August 31, 2016
Sales and Marketing Pfizer, Xalkori, lung cancer, non-small cell lung cancer

The European Commission has approved Pfizer’s Xalkori (crizotinib) for the treatment of adults with ROS1-positive advanced non-small cell lung cancer …

News

Recipharm establishes long term supply agreement with Tillotts Pharma AG

August 31, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), announces that it has entered into a long term supply agreement with …

News
Press release
pharmafocus_sept_2016_cover

The September issue of Pharmafocus is now live!

August 31, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myer's Squibb, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, Cloud Computing, Pharmafocus, Pharmafocus new issue, brexit, clinical trial transparaency, opdivo

The latest edition of Pharmafocus is available online now. In this issue, we explore the future of the clinical trial …

News

AstraZeneca to pay £5.52 million to settle bribery probe

August 31, 2016
Research and Development AstraZeneca, SEC, misconduct

According to US regulators, AstraZeneca is to pay $5.52 million to resolve a foreign bribery probe investigating payments made to …

News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026